for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioMerieux SA

BIOX.PA

Latest Trade

115.60EUR

Change

-1.80(-1.53%)

Volume

67,007

Today's Range

114.95

 - 

118.20

52 Week Range

88.86

 - 

133.20

As of on the Euronext Paris ∙ Minimum 15 minute delay

Pricing

Previous Close
117.40
Open
117.80
Volume
67,007
3M AVG Volume
2.88
Today's High
118.20
Today's Low
114.95
52 Week High
133.20
52 Week Low
88.86
Shares Out (MIL)
118.10
Market Cap (MIL)
13,895.61
Forward P/E
26.57
Dividend (Yield %)
0.53

Next Event

Full Year 2021 Biomerieux SA Earnings Release

Latest Developments

More

Biomerieux Revises Upwards Its 2021 Targets

Biomerieux H1 EBITDA Up At 471 Million Euros, Confirms FY Targets

Biomerieux, Specific Diagnostics Sign Co-Exclusive Distribution Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BioMerieux SA

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Industry

Biotechnology & Drugs

Contact Info

5, rue des Aqueducs

69290

France

+33.4.78872000

http://www.biomerieux.fr/

Executive Leadership

Alexandre Merieux

Chairman of the Board, Chairman of the Executive Committee, Chief Executive Officer, Non-Independent Director

Guillaume Bouhours

Executive Vice President Purchasing and Information Systems, Chief Financial Officer, Member of the Executive Committee

Pierre Boulud

Chief Operating Officer, Clinical Operations, Member of the Executive Committee

Valerie Leylde

Executive Vice President of Human Resources and Communications, Member of the Executive Committee

Francois Lacoste

Executive Vice President, R&D, Member of the Executive Committee

Key Stats

2.00 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2018

2.4K

2019

2.7K

2020

3.1K

2021(E)

3.3K
EPS (EUR)

2018

2.170

2019

2.300

2020

3.410

2021(E)

4.419
Price To Earnings (TTM)
27.43
Price To Sales (TTM)
4.32
Price To Book (MRQ)
5.14
Price To Cash Flow (TTM)
18.75
Total Debt To Equity (MRQ)
19.45
LT Debt To Equity (MRQ)
13.40
Return on Investment (TTM)
16.55
Return on Equity (TTM)
12.25

Latest News

Latest News

BRIEF-BioMerieux H1 Revenue Up 15.7% Organically At EUR 1.48 Bln

* ORGANIC GROWTH OF 15.7% AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION OVER FIRST HALF OF 2020: EUR 1,476 MILLION IN SALES

BRIEF-bioMerieux: CE Marking of VIDAS anti-SARS-CoV-2 Tests

* CE MARKING OF BIOMÉRIEUX SEROLOGY TESTS FOR SARS-COV-2 ON VIDAS®

BRIEF-bioMerieux Reduces 2019 Dividend To 0.19 Euros Per Share

* BOARD OF DIRECTORS EXCEPTIONALLY RECOMMENDED REDUCING DIVIDEND TO EUR 0.19 PER SHARE

France's BioMerieux launches product to identify coronavirus antibodies

French diagnostics specialist BioMérieux announced on Wednesday the launch of a new product that aims to detect within 30 minutes the presence of antibodies in those exposed to the coronavirus.

BRIEF-Biomerieux: BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization

* BIOMÉRIEUX: BIOFIRE® RESPIRATORY PANEL 2.1 (RP2.1) WITH SARS-COV-2 OBTAINS FDA EMERGENCY USE AUTHORIZATION

Exclusive: Canada gets Biomerieux formula for free to produce virus testing chemicals

A key supplier of the chemicals needed to test for coronavirus, France's Biomérieux <BIOX.PA>, has given its proprietary formula to the Canadian government for free so its national lab can try to manufacture badly-needed test kits on its own, according to federal officials...

BRIEF-Biomerieux Posts Q1 Sales Up 21.5% YOY, Withdraws Outlook

* SHARP SALES INCREASE FOR MOLECULAR BIOLOGY PRODUCT LINES, DRIVEN BY EXCEPTIONAL DEMAND FOR RESPIRATORY TESTS

BRIEF-bioMerieux Postpones AGM To June 30

* ANNOUNCED ON THURSDAY DECISION TO POSTPONE ANNUAL GENERAL MEETING INITIALLY SCHEDULED ON MAY 19, 2020 TO JUNE 30, 2020

BRIEF-Biomerieux Gets U.S. Approval For Biofire Covid-19 Test

* BIOMERIEUX RECEIVES EMERGENCY USE AUTHORIZATION FOR BIOFIRE® COVID-19 TEST

French group Biomerieux gets U.S. approval for coronavirus testing product

Biomérieux, a French healthcare company specialising in diagnostics, said on Tuesday that it had won approval from the U.S. Food & Drug Administration (FDA) for its 'biofire®' product aimed at testing for coronavirus.

French group Biomerieux launches three coronavirus tests

French healthcare company Biomerieux announced on Wednesday the launch of three tests to help fight a coronavirus that has killed thousands worldwide, and the updates lifted BioMerieux's shares.

French group Biomerieux launches three coronavirus tests

French healthcare company Biomerieux announced on Wednesday the launch of three tests to help fight a coronavirus that has killed thousands worldwide.

BRIEF-Dassault places 0.5 % of Biomerieux capital - Banks

* GROUPE INDUSTRIEL MARCEL DASSAULT LAUNCHES A PLACEMENT OF BIOMÉRIEUX SHARES, TO PLACE 600,000 SHARES IN BIOMERIEUX, OR 0.5% OF CAPITAL - BANKS

Turkey's BIM 2018 net profit jumps 45 percent to 1.25 bln lira

Turkish discount retailer BIM posted a net profit of 1.25 billion lira ($230 million) in 2018, up 45 percent from a year earlier, it said late on Wednesday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up